Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Chromatin Regulator Mutations Are Drivers of Clonal Evolution in the Early Multipotent HSC Compartment of Primary Myelofibrosis

Ioanna Triviai, Jan Rentel, Silke Zeschke, Carol Stocking, PhD, Kroger Nicolaus

Blood (2017) 130 (Supplement 1): 1658.

https://doi.org/10.1182/blood.V130.Suppl_1.1658.1658

Published: 2017

Journal Articles

ASXL1 Mutation Change the Migration Ability in JAK2V617F Positive Cell Lines through SDF-1/CXCR4 Axis

Jinqin Liu, Bing Li, Yi Li, Gang Huang, PhD, Zhijian Xiao

Blood (2017) 130 (Supplement 1): 1666.

https://doi.org/10.1182/blood.V130.Suppl_1.1666.1666

Published: 2017

Journal Articles

Regulation of the Tumor Microenvironment By High Molecular Weight Kininogen

Meenal Shukla, PhD, Venkaiah Betapudi, PhD, Ravi Kumar Alluri, PhD, Sergei Merkulov, PhD, James Hale, PhD, Justin Lathia, PhD, Keith R. McCrae, MD

Blood (2016) 128 (22): 1394.

https://doi.org/10.1182/blood.V128.22.1394.1394

Published: 2016

Journal Articles

Potent Inhibition of the Growth and Induction of Apoptosis in Lymphoma By the Anthelminthic Drug Niclosamide: In Vitro Data

Junaid Ansari, MD, Paula Polk, Jeffrey Aufman, MD, Guillermo A Herrera, MD, James Cardelli, PhD, Reinhold Munker, MD

Blood (2015) 126 (23): 5131.

https://doi.org/10.1182/blood.V126.23.5131.5131

Published: 2015

Journal Articles

Single Cell RNA Sequencing Reveals Increased Adhesion Signals in Treatment-Resistant Tumor Stem Cells in a Preclinical Mouse Model of Genetically Engineered Patient-Derived Acute Lymphoblastic Leukemia

Ebinger Sarah, M. Sc., Özdemir Erbey, M. Sc., Sebastian Tiedt, PhD, Christoph Ziegenhain, M. Sc., Catarina Castro Alves, PhD, Wolfgang Enard, Prof. Dr. rer. nat., Irmela Jeremias, MD

Blood (2015) 126 (23): 2630.

https://doi.org/10.1182/blood.V126.23.2630.2630

Published: 2015

Journal Articles

EZH2 Mutations Are Drivers of Clonal Hematopoiesis and Leukemic Transformation in a Mouse Model of Primary Myelofibrosis

Ioanna Triviai, PhD, Thomas Stuebig, MD, Anita Badbaran, Silke Zeschke, Victoria Panagiota, MD, Michael Heuser, MD, Carol Stocking, Nicolaus Kroger, MD

Blood (2014) 124 (21): 3211.

https://doi.org/10.1182/blood.V124.21.3211.3211

Published: 2014

Journal Articles

Clinical Relevance of CD45+/CD19- Stem-like Tumor Cells in Patients with Mantle Cell Lymphoma: A Single Center Experience

Sung Min Kim, Seung-Tae Lee, MD, Kyung Ju Ryu, Hee-Jin Kim, Sun-Hee Kim, Kwai Han Yoo, Young Hyeh Ko, MD PhD, Won Seog Kim, MD PhD, Seok Jin Kim, MD PhD

Blood (2014) 124 (21): 1622.

https://doi.org/10.1182/blood.V124.21.1622.1622

Published: 2014

Journal Articles

A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies

Jeffrey E Lancet, MD, Andrew H Wei, MBBS, PhD, Simon TS Durrant, Mark S. Hertzberg, MBBS, PhD, FRACP, FRCPA, Ronan T. Swords, MD, PhD, FRCPI, FRCPath, Ian D Lewis, MB, BS, PhD, Brian Jonas, MD, PhD, Jorge E. Cortes, MD, Geoffrey Yarranton, PhD, Jackie M. Walling, MBChB, PhD

Blood (2013) 122 (21): 3838.

https://doi.org/10.1182/blood.V122.21.3838.3838

Published: 2013

Journal Articles

The Oncogenic Transcription Factor STAT5 Triggers Aberrant Expression Of CD25 (IL-2RA) In Neoplastic Stem Cells In Ph + CML

Irina Sadovnik, M.Sc., Harald Herrmann, M.D., Sabine Cerny-Reiterer, D.V.M, Wolfgang Warsch, Ph.D., Andrea Hoelbl, Ph.D., Katharina Blatt, MSc, Ph.D., Barbara Peter, D.V.M., Gabriele Stefanzl, Msc, Gregor Hoermann, M.D., Ph.D., Susanne Herndlhofer, Berthold Streubel, M.D., Wolfgang R Sperr, M.D., Christine Mannhalter, Ph.D., Veronika Sexl, MD, Peter Valent

Blood (2013) 122 (21): 3979.

https://doi.org/10.1182/blood.V122.21.3979.3979

Published: 2013

Journal Articles

Expression of the CAMPATH-1 Antigen (CD52) on CD34+/CD38- Progenitor Cells in Patients with 5q- MDS and in a Subset of AML

Katharina Blatt, M.Sc., Harald Herrmann, M.D., Sabine Cerny-Reiterer, D.V.M., Susanne Herndlhofer, Wolfgang R. Sperr, M.D., Peter Valent, M.D.

Blood (2011) 118 (21): 1728.

https://doi.org/10.1182/blood.V118.21.1728.1728

Published: 2011

Journal Articles

5-Azacytidine and Decitabine Induce Demethylation and Re-Expression of FAS (CD95) and Promote Apoptosis in Neoplastic Cells in Acute Myeloid Leukemia (AML),

Heidrun Karlic, PhD, Rene Reitermaier, Viviane Ghanim, MD, Harald Herrmann, MD, Roman Thaler, M.Sc. PhD, Silvia Spitzer, Franz Varga, PhD, Irina Sadovnik, M.Sc., Katharina Blatt, M.Sc., Felix Keil, MD, Peter Valent, M.D., Michael Pfeilstöcker, MD

Blood (2011) 118 (21): 3463.

https://doi.org/10.1182/blood.V118.21.3463.3463

Published: 2011

Journal Articles

Identification of Novel Surface Markers and Targets In Neoplastic Stem Cells In AML and CML: a Flow-Gene-Flow Screen Approach.

Harald Herrmann, M.D., Sabine Cerny-Reiterer, D.V.M., Irina Sadovnik, M.Sc., Viviane Winter, M.D., Katharina Blatt, M.Sc., Werner Rabitsch, M.D., Wolfgang R. Sperr, M.D., Elena De Angelis, Ph.D., Steve Holmes, Ph.D., Peter Valent, M.D.

Blood (2010) 116 (21): 1575.

https://doi.org/10.1182/blood.V116.21.1575.1575

Published: 2010

Journal Articles

Nilotinib and Dasatinib Produce Synergistic Growth-Inhibitory Effects In Imatinib-Resistant CML Cells, Including Subclones Bearing the Multi-Resistant BCR/ABL Mutant T315I

Karoline V. Gleixner, Harald Herrmann, Irina Sadovnik, Karina Schuch, Winfried F Pickl, Christian Sillaber, Peter Valent

Blood (2010) 116 (21): 2280.

https://doi.org/10.1182/blood.V116.21.2280.2280

Published: 2010

Journal Articles

Effective Alloreactive NK Cell Therapy for Breast Cancer In Mice Requires Conditioning with Cyclophosphamide and Total Body Irradiation but Not Bone Marrow Engraftment

Michel Van Gelder, Peter Frings, Catarina Matos, Harry C. Schouten, Gerard M.J. Bos

Blood (2010) 116 (21): 2085.

https://doi.org/10.1182/blood.V116.21.2085.2085

Published: 2010

Journal Articles

Alloreactive NK-Cells Cure Tumor Stem Cell Containing Breast Cancer.

Michel Van Gelder, MD, PhD, Peter Frings, Catarina Matos, technician, Gerard Bos, MD, PhD, Harry Schouten, Pierre Hupperets, medical, oncologist

Blood (2009) 114 (22): 4082.

https://doi.org/10.1182/blood.V114.22.4082.4082

Published: 2009

Journal Articles

Vector Prime-Protein Boost Vaccine Induces 20 Fold Decrease in the Levels of CD44 + CD24 −/Low Cancer Stem Cells in Epithelial Neoplasms

Yucheng Tang, MD, PhD, Hakan Akbulut, MD, Jonathan Maynard, Pingchaun Li, PhD, Albert B. Deisseroth, MD, PhD

Blood (2008) 112 (11): 2908.

https://doi.org/10.1182/blood.V112.11.2908.2908

Published: 2008

Journal Articles

ABCG2 Is Expressed in a Small Population of Circulating CLL B-Cells Characterized by Expression of Self-Renewal and Early B-Cell Development Genes and Resistance to Therapy

Grzegorz S. Nowakowski, Xiaosheng Wu, Jennifer L. Abrahamzon, Renee Tschumper, Neil E. Kay, Diane F. Jelinek

Blood (2008) 112 (11): 3156.

https://doi.org/10.1182/blood.V112.11.3156.3156

Published: 2008

Journal Articles

Direct Confirmation of Quiescent Property of AML Stem Cells by Showing Markedly Decreased Plating Efficiency in Single Leukemic Stem Cell Culture

Myung-Geun Shin, Hye-Ran Kim, Chang-Soo Kim, Hyeoung-Joon Kim, Hoon Kook, Seung- Jung Kee, Soo-Hyun Kim, Jong-Hee Shin, Soon-Pal Suh, Dong-Wook Ryang

Blood (2008) 112 (11): 4737.

https://doi.org/10.1182/blood.V112.11.4737.4737

Published: 2008

Journal Articles

Proteomics To Identify Novel Immune-Targeted CML Stem Cell Antigens.

Melinda A. Biernacki, Ovidiu Marina, Liu Fenglong, Ingmar Bruns, MD, David Zahrieh, Wandi Zhang, Christine Canning, PA-C, Edwin P. Alyea, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Catherine J. Wu, MD

Blood (2007) 110 (11): 1799.

https://doi.org/10.1182/blood.V110.11.1799.1799

Published: 2007

Journal Articles

Glioma Vaccines Generated from Electrofusion of Dendritic Cells and Brain Tumor Stem Cells.

Gregory Plautz, MD, Gene H. Barnett, MD, Cameron Nicholson, MD, Suyu Shu, PhD

Blood (2006) 108 (11): 5193.

https://doi.org/10.1182/blood.V108.11.5193.5193

Published: 2006

NARROW

Chromatin Regulator Mutations Are Drivers of Clonal Evolution in the Early Multipotent HSC Compartment of Primary Myelofibrosis

ASXL1 Mutation Change the Migration Ability in JAK2V617F Positive Cell Lines through SDF-1/CXCR4 Axis

Regulation of the Tumor Microenvironment By High Molecular Weight Kininogen

Potent Inhibition of the Growth and Induction of Apoptosis in Lymphoma By the Anthelminthic Drug Niclosamide: In Vitro Data

Single Cell RNA Sequencing Reveals Increased Adhesion Signals in Treatment-Resistant Tumor Stem Cells in a Preclinical Mouse Model of Genetically Engineered Patient-Derived Acute Lymphoblastic Leukemia

EZH2 Mutations Are Drivers of Clonal Hematopoiesis and Leukemic Transformation in a Mouse Model of Primary Myelofibrosis

Clinical Relevance of CD45+/CD19- Stem-like Tumor Cells in Patients with Mantle Cell Lymphoma: A Single Center Experience

A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies

The Oncogenic Transcription Factor STAT5 Triggers Aberrant Expression Of CD25 (IL-2RA) In Neoplastic Stem Cells In Ph + CML

Expression of the CAMPATH-1 Antigen (CD52) on CD34+/CD38- Progenitor Cells in Patients with 5q- MDS and in a Subset of AML

5-Azacytidine and Decitabine Induce Demethylation and Re-Expression of FAS (CD95) and Promote Apoptosis in Neoplastic Cells in Acute Myeloid Leukemia (AML),

Identification of Novel Surface Markers and Targets In Neoplastic Stem Cells In AML and CML: a Flow-Gene-Flow Screen Approach.

Nilotinib and Dasatinib Produce Synergistic Growth-Inhibitory Effects In Imatinib-Resistant CML Cells, Including Subclones Bearing the Multi-Resistant BCR/ABL Mutant T315I

Effective Alloreactive NK Cell Therapy for Breast Cancer In Mice Requires Conditioning with Cyclophosphamide and Total Body Irradiation but Not Bone Marrow Engraftment

Alloreactive NK-Cells Cure Tumor Stem Cell Containing Breast Cancer.

Vector Prime-Protein Boost Vaccine Induces 20 Fold Decrease in the Levels of CD44 + CD24 −/Low Cancer Stem Cells in Epithelial Neoplasms

ABCG2 Is Expressed in a Small Population of Circulating CLL B-Cells Characterized by Expression of Self-Renewal and Early B-Cell Development Genes and Resistance to Therapy

Direct Confirmation of Quiescent Property of AML Stem Cells by Showing Markedly Decreased Plating Efficiency in Single Leukemic Stem Cell Culture

Proteomics To Identify Novel Immune-Targeted CML Stem Cell Antigens.

Glioma Vaccines Generated from Electrofusion of Dendritic Cells and Brain Tumor Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only